Furthermore, chemically inhibiting EDNRA inhibits invasion in breast cancer cell lines 19, and ET1 and ET2 both induce breast cancer cell migration in an EDNRA and EDNRB-dependent manner 16,20. Here, EDN2 is linked to breast carcinoma.